3min snip

The Model Health Show cover image

TMHS 772: Facts About Ozempic, Long-Term Weight Loss, & Gut Health – with Dr. William Davis

The Model Health Show

NOTE

Critique of Weight Loss Drugs and FDA Approval

Weight loss drugs, despite being touted as innovative solutions, typically function by reducing calorie intake. However, once individuals discontinue these drugs, they often experience weight regain, mainly in fat, while losing muscle mass. This cycle leads to increased insulin resistance, pre-diabetes, and higher risks of diseases like diabetes, heart disease, cognitive impairment, and cancer. The approval of such drugs by the FDA has resulted in a significant negative impact on the health of Americans, creating a costly and detrimental long-term scenario. The weight regain associated with muscle loss also predisposes individuals to frailty, loss of independence, reduced mobility, and insulin sensitivity. This approach not only leads to weight issues but also compromises overall health in the long run. Despite claims of being breakthrough solutions, these drugs offer only temporary relief and pose severe long-term health consequences. The focus should shift towards managing body composition effectively, rather than solely aiming for weight loss.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode